Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)

Ingmar Skoog, Hans Lithell, Lennart Hansson, Dag Elmfeldt, Albert Hofman, Bertil Olofsson, Peter Trenkwalder, Alberto Zanchetti

Research output: Contribution to journalArticlepeer-review

Abstract

Background: We examined whether cognitive function at baseline affected cognitive and cardiovascular outcomes in the Study on COgnition and Prognosis in the Elderly (SCOPE), a blood pressure (BP)-lowering intervention trial. Methods: SCOPE included 4937 patients, aged 70 to 89 years, with mild-to-moderate hypertension and Mini Mental State Examination (MMSE) score

Original languageEnglish
Pages (from-to)1052-1059
Number of pages8
JournalAmerican Journal of Hypertension
Volume18
Issue number8
DOIs
Publication statusPublished - Aug 2005

Keywords

  • Candesartan
  • Cognitive function
  • Elderly
  • Hypertension
  • Outcomes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)'. Together they form a unique fingerprint.

Cite this